PROTECTION FROM LETHAL CORONAVIRUS INFECTION BY AFFINITY-PURIFIED SPIKE GLYCOPROTEIN OF MURINE HEPATITIS-VIRUS, STRAIN-A59

被引:37
作者
DANIEL, C [1 ]
TALBOT, PJ [1 ]
机构
[1] UNIV QUEBEC,INST ARMAND FRAPPIER,VIROL RES CTR,531 BLVD PRAIRIES,LAVAL H7N 4Z3,QUEBEC,CANADA
基金
英国医学研究理事会; 加拿大自然科学与工程研究理事会;
关键词
D O I
10.1016/0042-6822(90)90057-X
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Murine hepatitis viruses provide excellent animal models for the study of virus-induced diseases of the central nervous system and gastrointestinal tract. Several studies have indirectly provided evidence that the spike glycoprotein (S) of these coronaviruses bears determinants for pathogenesis and the induction of protective immunity. In order to directly evaluate the immunogenicity of this protein, it was purified by affinity chromatography with an in vitro neutralizing and in vivo protective monoclonal antibody which immunoprecipitated the 180-kDa spike glycoprotein of the neurotropic A59 strain of murine hepatitis virus (MHV-A59). Mice immunized twice with approximately 1 μg of purified S in Freund's adjuvant developed high titers of neutralizing and fusion inhibiting antibodies, even though the protein was at least partially denaturated after elution from the affinity column. Moreover, these mice were protected from lethal encephalitis when challenged intracerebrally with 10 LD50 of MHV-A59. This study provides a direct demonstration of the importance of the coronavirus spike glycoprotein in the induction of a protective immune response. © 1990.
引用
收藏
页码:87 / 94
页数:8
相关论文
共 35 条
[1]   MURINE HEPATITIS VIRUS-4 (STRAIN JHM)-INDUCED NEUROLOGIC DISEASE IS MODULATED INVIVO BY MONOCLONAL-ANTIBODY [J].
BUCHMEIER, MJ ;
LEWICKI, HA ;
TALBOT, PJ ;
KNOBLER, RL .
VIROLOGY, 1984, 132 (02) :261-270
[2]   MONOCLONAL-ANTIBODIES TO MURINE HEPATITIS VIRUS-4 (STRAIN-JHM) DEFINE THE VIRAL GLYCOPROTEIN RESPONSIBLE FOR ATTACHMENT AND CELL CELL-FUSION [J].
COLLINS, AR ;
KNOBLER, RL ;
POWELL, H ;
BUCHMEIER, MJ .
VIROLOGY, 1982, 119 (02) :358-371
[3]   SITE-SPECIFIC ALTERATION OF MURINE HEPATITIS-VIRUS TYPE-4 PEPLOMER GLYCOPROTEIN-E2 RESULTS IN REDUCED NEUROVIRULENCE [J].
DALZIEL, RG ;
LAMPERT, PW ;
TALBOT, PJ ;
BUCHMEIER, MJ .
JOURNAL OF VIROLOGY, 1986, 59 (02) :463-471
[4]   PHYSICOCHEMICAL PROPERTIES OF MURINE HEPATITIS-VIRUS, STRAIN-A59 [J].
DANIEL, C ;
TALBOT, PJ .
ARCHIVES OF VIROLOGY, 1987, 96 (3-4) :241-248
[5]  
ERLICH SS, 1985, PATHOLOGY MYELINATED, P276
[6]   MONOCLONAL-ANTIBODIES TO THE MATRIX (E1) GLYCOPROTEIN OF MOUSE HEPATITIS-VIRUS PROTECT MICE FROM ENCEPHALITIS [J].
FLEMING, JO ;
SHUBIN, RA ;
SUSSMAN, MA ;
CASTEEL, N ;
STOHLMAN, SA .
VIROLOGY, 1989, 168 (01) :162-167
[7]   PATHOGENICITY OF ANTIGENIC VARIANTS OF MURINE CORONAVIRUS JHM SELECTED WITH MONOCLONAL-ANTIBODIES [J].
FLEMING, JO ;
TROUSDALE, MD ;
ELZAATARI, FAK ;
STOHLMAN, SA ;
WEINER, LP .
JOURNAL OF VIROLOGY, 1986, 58 (03) :869-875
[8]  
GILMORE W, 1987, P SOC EXP BIOL MED, V185, P177
[9]   USE OF AVIDIN-BIOTIN INTERACTION IN IMMUNOENZYMATIC TECHNIQUES [J].
GUESDON, JL ;
TERNYNCK, T ;
AVRAMEAS, S .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1979, 27 (08) :1131-1139
[10]   ANTIGENICITY OF MOUSE HEPATITIS-VIRUS STRAIN 3 SUB-COMPONENTS IN C57 STRAIN MICE [J].
HASONY, HJ ;
MACNAUGHTON, MR .
ARCHIVES OF VIROLOGY, 1981, 69 (01) :33-41